Bimosiamose disodium structure
|
Common Name | Bimosiamose disodium | ||
|---|---|---|---|---|
| CAS Number | 187269-60-9 | Molecular Weight | 906.875 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C46H52Na2O16 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Bimosiamose disodiumBimosiamose disodium (TBC-1269Z) is a nonoligosaccharide pan-selectin inhibitor with IC50s of 88 μM, 20 μM, and 86 μM for E-selectin, P-selectin, and L-selectin, respectively. Bimosiamose disodium has anti-inflammatory effects[1]. |
| Name | Bimosiamose disodium |
|---|---|
| Synonym | More Synonyms |
| Description | Bimosiamose disodium (TBC-1269Z) is a nonoligosaccharide pan-selectin inhibitor with IC50s of 88 μM, 20 μM, and 86 μM for E-selectin, P-selectin, and L-selectin, respectively. Bimosiamose disodium has anti-inflammatory effects[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 88 μM (E-selectin), 20 μM (P-selectin), and 86 μM (L-selectin)[1] |
| In Vitro | Bimosiamose (TBC-1269) operates by inhibiting neutrophil recruitment to the site of inflammation through blocking the initial rolling phase of recruitment. Bimosiamose (TBC-1269) inhibits cell recruitment and does not possess any cytotoxic effect on neutrophils[1]. |
| In Vivo | Bimosiamose (TBC-1269; 25 mg/kg; intravenous injection; Sprague-Dawley rats) treatment shows a significant increase in survival. Best overall survival, 70%, is observed when TBC-1269 is administered 15 minutes before reperfusion, and also shows a marked decrease in liver enzyme levels at 6 hours after reperfusion. Neutrophil migration is also significantly ameliorated (81%). The histologic damage scores is also improved[1]. Animal Model: Sprague-Dawley rats (200-225g) with ischemia and reperfusion (I/R)[1] Dosage: 25 mg/kg Administration: Intravenous injection Result: Showed a significant increase in survival compared with controls. |
| References |
| Molecular Formula | C46H52Na2O16 |
|---|---|
| Molecular Weight | 906.875 |
| Exact Mass | 906.305054 |
| [1,1'-Biphenyl]-3-acetic acid, 3',3''-(1,6-hexanediyl)bis[6'-(α-D-mannopyranosyloxy)-, sodium salt (1:2) |
| Disodium 2,2'-{1,6-hexanediylbis[6'-(α-D-mannopyranosyloxy)-3',3-biphenyldiyl]}diacetate |
| Bimosiamose disodium |
| 7AK2FKB9AW |
| UNII:7AK2FKB9AW |